Tag: rna sequencing services market opportunities

Uncover key drivers, emerging technologies, and competitive movements shaping the rna sequencing services market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the RNA Sequencing Services Market expected to reach by 2030?

The rna sequencing services market has seen swift growth over recent years. Its value is projected to increase from $3.99 billion in 2025 to $4.44 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.2%. The expansion observed historically can be linked to several factors, including a rise in genomic research funding, the proliferation of academic and government research endeavors, the increasing application of sequencing in fundamental biology studies, the decreasing expenses associated with sequencing technologies, and greater access to sequencing service providers.

The rna sequencing services market size is projected to experience robust expansion over the coming years. This market is anticipated to reach $6.38 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. Several factors will drive this growth during the forecast period, including the increasing embrace of precision medicine approaches, a heightened need for transcriptomic data in diagnostics, an expansion of pharmaceutical research and development activities, the growing incorporation of AI-driven data analytics, and increased outsourcing of sequencing services. Key trends for the forecast period encompass a rising requirement for high-throughput transcriptomic analysis, the increasing uptake of NGS-based rna sequencing, the broadening of bioinformatics-integrated sequencing services, an escalating application of rna sequencing in clinical research, and an intensified emphasis on data accuracy and reproducibility.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

What Drivers Are Driving Adoption Within The RNA Sequencing Services Market?

The increasing need for customized medical care significantly fuels the expansion of the RNA sequencing services market. Personalized medicine involves adapting medical treatments to specific individual characteristics, such as genetics or lifestyle, to optimize effectiveness and minimize adverse reactions. The rising demand for personalized medicine stems from its potential to deliver more effective therapies, advancements in genomics, the growing complexity of diseases, and regulatory backing. RNA sequencing services play a crucial role in identifying disease subtypes, discovering biomarkers, pinpointing therapeutic targets, predicting treatment responses, and monitoring disease progression and treatment outcomes. Personalized medicine approaches utilize RNA sequencing technologies to provide individualized and effective medications that target the unique molecular characteristics of each patient. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA (Food and Drug Administration) approved 16 novel personalized therapies for patients with rare diseases in 2023, which is an increase from six in 2022. The personalized treatments newly sanctioned for 2023 also comprised seven cancer drugs and three for other diseases and conditions. Thus, the escalating requirement for personalized medicine is driving the growth of the RNA sequencing services market moving forward.

How Is The RNA Sequencing Services Market Organized Into Various Segments?

The rna sequencing services market covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods

3) By Application Area: Research Purposes, Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing

Which Trends Are Guiding The Evolution Of The RNA Sequencing Services Market?

Major companies operating in the RNA sequencing services market are increasingly focusing on automation, exemplified by the next-generation sequencing (NGS) assay, to mitigate potential human error and enhance the efficiency and accuracy of data generation and analysis. The RNA next-generation sequencing (RNA-seq) assay is recognized as a powerful tool in molecular biology and genomics for analyzing the transcriptome of a biological sample. For instance, in June 2023, Tempus, a US-based precision medicine technology company, launched its new standalone RNA next-generation sequencing assay, known as Tempus xR. This innovative assay, tailored for solid tumors, provides a comprehensive analysis of the entire transcriptome, highlighting clinically significant fusions in over 100 targeted genes, along with altered splicing for MET Exon 14 and EGFRvIII. Recognizing the importance of RNA sequencing data, Tempus has historically integrated both RNA and DNA sequencing into its standard xT broad-panel assay. Now, clients are offered the flexibility to order each test separately or simultaneously, with the option to augment xR with specific Tempus algorithmic tests. This offering is designed to serve physicians with a particular interest in RNA fusions or altered splicing, as well as providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis of their existing samples.

Who Are The Prominent Global Companies Shaping The RNA Sequencing Services Market Landscape?

Major companies operating in the rna sequencing services market are Thermo Fisher Scientific Inc., Illumina Inc., Qiagen NV, BGI Genomics Co Ltd, Azenta Inc., Novogene Co Ltd, Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, Genomax Technologies Pte Ltd, Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics, Novaseq Services Ltd

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The RNA Sequencing Services Market?

North America was the largest region in the RNA sequencing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rna sequencing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized RNA Sequencing Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp

Browse Through More Reports Similar to the Global RNA Sequencing Services Market 2026, By The Business Research Company

Genomics Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Ngs Based Rna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Ribonucleic Acid Rna Sequencing Market Report 2026

https://www.thebusinessresearchcompany.com/report/ribonucleic-acid-rna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Big Is The RNA Sequencing Services Market Today And What Is Its Future Size?

In recent years, the RNA sequencing services market has experienced significant growth. It’s expected to rise from $3.58 billion in 2024 to $3.99 billion in 2025, with an annual compound growth rate of 11.4%. The previously seen growth in this sector can be linked to a greater interest in personalized medicine, improvements in bioinformatics tools, an increased emphasis on drug discovery and development, augmented utilization of RNA sequencing in agricultural studies, and a broader application in clinical diagnostics.

In the coming years, the rna sequencing services market size is predicted to experience a rapid expansion. By 2029, it’s predicted to reach a value of $5.92 billion, growing at a compound annual growth rate (CAGR) of 10.4%. Factors such as the development of single-cell RNA sequencing technologies, incorporation of artificial intelligence and machine learning into data interpretation, expanding research into non-coding RNA biomarkers, increasing demand for transcriptomic analysis in the field of immunotherapy research, and strengthening collaborations between academic and industrial entities for genomic studies are the key drivers of growth during the forecast period. A shift towards adopting long-read sequencing, deploying cloud-based platforms for analysis, escalating demand for RNA splicing analysis, and integrating multi-omics data are expected to be major trends throughout the forecast period.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

What External And Internal Drivers Are Influencing The RNA Sequencing Services Market?

The RNA sequencing services market is experiencing significant expansion due to the rising need for personalized medicine. Personalized medicine encompasses customizing medical care based on individual traits, including genetics and lifestyle, enhancing the drug’s efficacy while minimizing side effects. The increasing interest in personalized medicine stems from its capability to offer more efficient treatments, advances in genomics, escalating complexity of diseases, and advantageous regulatory support. RNA sequencing services facilitate disease subtype identification, biomarker discovery, therapeutic target recognition, therapy response prediction, and monitoring of disease progression and treatment outcomes. Personalized medicine methodologies employ RNA sequencing technologies to develop individualized and effective drugs that target distinct molecular traits of individual patients. For instance, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the US, revealed that the FDA (Food and Drug Administration) gave the green light to 16 innovative personalized therapies for patients with rare diseases in 2023, in contrast to six in 2022. The freshly approved personalized treatments for 2023 also consist of seven drugs for cancer and three other diseases and conditions. Consequently, the surging demand for personalized medicine is propelling the growth of the RNA sequencing services market in the future.

How Is The RNA Sequencing Services Market Categorized Across Applications And Types?

The rna sequencing servicesmarket covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA); Transfer RNA (tRNA); Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods; Other Sequencing Methods

3) By Application Area: Research Purposes; Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing; RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling; TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling; lncRNA Sequencing

How Are Industry Trends Steering The Expansion Of The RNA Sequencing Services Market?

Leading businesses in the RNA sequencing services market, like the next-generation sequencing (NGS) assay, are embracing automation to minimize human errors and increase the effectiveness and precision of data creation and examination. The RNA next-generation sequencing (RNA-seq) assay is a potent tool employed in molecular biology and genomics for decoding the transcriptome of a biological specimen. Tempus, a precision medicine technology business in the United States, launched its standalone RNA next-generation sequencing assay titled Tempus xR in June 2023. This groundbreaking assay, intended for solid tumors, delivers an all-encompassing analysis of the entirety of the transcriptome, showcasing significant fusions in more than 100 targeted genes besides altered splicing for the MET Exon 14 and EGFRvIII. Acknowledging the importance of RNA sequencing data, Tempus has traditionally incorporated RNA and DNA sequencing into its standard xT broad-panel assay. Now, customers can choose to order each test individually or concurrently, with the chance to add specific Tempus algorithmic tests to xR. This offering is geared toward doctors concentrating on RNA fusions or altered splicing, and also suppliers, investigators, and biopharma companies looking for thorough RNA sequencing examination of their current samples.

Who Are The Global Leaders Steering The RNA Sequencing Services Market Forward?

Major companies operating in the RNA sequencing services market are Thermo Fisher Scientific Inc., Feng Chi Biotech Corp., Illumina Inc., Qiagen NV, BGI Genomics Co. Ltd., Azenta Inc., Abcam Limited, Novogene Co. Ltd., Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, RayBiotech Inc., Genomax Technologies Pte. Ltd., Phalanx Biotech Group Inc., Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

What Are The Emerging Regional Trends Driving The RNA Sequencing Services Market?

North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp

Browse Through More Reports Similar to the Global RNA Sequencing Services Market 2025, By The Business Research Company

Antisense And Rnai Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Rna Analysis Transcriptomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Ngs Based Rna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The RNA Sequencing Services Market By 2029?

The rna sequencing services market has experienced rapid expansion in recent years. Its valuation is projected to increase from $3.58 billion in 2024 to $3.99 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.4%. This historical growth can be attributed to factors such as the increasing demand for personalized medicine, progress in bioinformatics tools, a stronger focus on drug discovery and development, the rising integration of RNA sequencing into agricultural research, and its broadening applications in clinical diagnostics.

The rna sequencing services market size is projected to experience swift expansion in the upcoming years. This market is anticipated to reach $5.92 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.4%. Several factors are expected to drive this growth during the forecast period, including the advent of single-cell RNA sequencing technologies, the incorporation of artificial intelligence and machine learning into data analysis, increasing investigation into non-coding RNA biomarkers, a surging need for transcriptomic analysis within immunotherapy research, and escalating partnerships between academic institutions and industries in genomic studies. Key trends foreseen in this period encompass the adoption of long-read sequencing, the use of cloud-based analysis platforms, an increasing requirement for RNA splicing analysis, and the integration of multi-omics data.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

Which Major Market Drivers Are Shaping The Future Of The RNA Sequencing Services Market?

The RNA sequencing services market is significantly growing, largely driven by the increasing demand for personalized medicine. Personalized medicine refers to adapting medical treatment to individual traits, such as genetics or lifestyle, to maximize effectiveness and reduce negative effects. This rising demand for personalized medicine is propelled by its promise of more effective treatments, progress in genomics, the growing complexity of diseases, and regulatory support. RNA sequencing services are instrumental in identifying disease subtypes, discovering biomarkers, pinpointing therapeutic targets, predicting therapy responses, and monitoring disease progression and treatment outcomes. Personalized medicine techniques employ RNA sequencing technologies to deliver individualized and effective medicines that target the unique molecular characteristics of patients. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that the FDA (Food and Drug Administration) approved 16 novel personalized therapies for patients with rare diseases in 2023, an increase from six in 2022. The personalized treatments newly approved in 2023 also encompassed seven cancer drugs and three for other diseases and conditions. Consequently, the escalating demand for personalized medicine is fueling the growth of the RNA sequencing services market going forward.

Which Key Segments Fueling The RNA Sequencing Services Market?

The rna sequencing servicesmarket covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA); Transfer RNA (tRNA); Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods; Other Sequencing Methods

3) By Application Area: Research Purposes; Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing; RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling; TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling; lncRNA Sequencing

What Long-Term Trends Will Shape The Future Growth Of The RNA Sequencing Services Industry?

Major companies operating in the RNA sequencing services market are increasingly focusing on automation to minimize potential human error, particularly with next-generation sequencing (NGS) assays, aiming to significantly enhance the efficiency and accuracy of data generation and analysis processes. The RNA next-generation sequencing (RNA-seq) assay serves as a powerful instrument in molecular biology and genomics for analyzing the transcriptome of biological samples. For instance, in June 2023, Tempus, a US-based precision medicine technology company, introduced its new standalone RNA next-generation sequencing assay, known as Tempus xR. This innovative assay is specifically designed for solid tumors, delivering a comprehensive analysis of the entire transcriptome, which highlights clinically significant fusions in more than 100 targeted genes, alongside altered splicing for MET Exon 14 and EGFRvIII. Recognizing the critical nature of RNA sequencing data, Tempus has traditionally included both RNA and DNA sequencing within its standard xT broad-panel assay. Presently, clients have the flexibility to order each test either separately or at the same time, with the option to enhance xR with certain Tempus algorithmic tests. This offering is tailored to physicians with a specific interest in RNA fusions or altered splicing, as well as to providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis for their existing samples.

Which Major Firms Are Strengthening Their Position In The RNA Sequencing Services Industry?

Major companies operating in the RNA sequencing services market are Thermo Fisher Scientific Inc., Feng Chi Biotech Corp., Illumina Inc., Qiagen NV, BGI Genomics Co. Ltd., Azenta Inc., Abcam Limited, Novogene Co. Ltd., Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, RayBiotech Inc., Genomax Technologies Pte. Ltd., Phalanx Biotech Group Inc., Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The RNA Sequencing Services Market?

North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The RNA Sequencing Services Market Report:

https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp

Browse Through More Reports Similar to the Global RNA Sequencing Services Market 2025, By The Business Research Company

Antisense And Rnai Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Rna Analysis Transcriptomics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/rna-analysis-transcriptomics-global-market-report

Ngs Based Rna Sequencing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ngs-based-rna-sequencing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the RNA Sequencing Services Market In 2029?

The market size of RNA sequencing services has seen swift expansion in the past few years. The projections show that it is set to rise from $3.58 billion in 2024 to an impressive $3.99 billion in 2025, signifying a compound annual growth rate (CAGR) of 11.4%. Factors contributing to this advancement in the historical duration include a surging demand for bespoke medicine, progress in bioinformatics tools, intensified pursuit of drug discovery and development, growing utilization of RNA sequencing in agricultural research, coupled with broadening applications in the field of clinical diagnostics.

In the coming years, the rna sequencing services market is predicted to experience a swift increase in size. The value is projected to touch$5.92 billion by 2029 with a compound annual growth rate (CAGR) of 10.4%. This predicted growth in the coming period is credited to the introduction of single-cell RNA sequencing technologies, implementation of artificial intelligence with machine learning in data interpretation, broadening research in non-coding RNA biomarkers, increased necessity for transcriptomic study in immunotherapy research, and a surge in partnerships between educational institutions and industry in genomic studies. The substantial trends for the forecast period comprise the adoption of long-read sequencing, cloud-based analysis platforms, the need for RNA splicing analysis, and the integration of multi-omics data.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

What Are the Core Growth Drivers Propelling the RNA Sequencing Services Market Forward?

The escalation in the need for personalized medicine plays a considerable part in boosting the RNA sequencing services market. Personalized medicine is the approach of customizing medical treatment to individual attributes, such as genetic makeup or lifestyle, with the main objective of enhancing effectiveness and minimizing negative effects. Factors propelling demand for personalized medicine stem from its ability to offer more efficient treatments, progress in genomics, rise in disease complexity, and regulatory backing. RNA sequencing services aid in identifying disease subclasses, discovering biomarkers, pinpointing therapeutic targets, predicting therapy outcomes, and monitoring disease development and treatment effects. Techniques of personalized medicine employ RNA sequencing technologies to deliver customized and effective medicines that are specially targeted to an individual patient’s unique molecular characteristics. As an example, in February 2024, the Personalized Medicine Coalition, a not-for-profit organization based in the US, revealed that the FDA (Food and Drug Administration) gave approval to 16 innovative personalized therapies in 2023 for patients with rare diseases, a significant increase from six in 2022. The fresh batch of approved personalized treatments in 2023 also comprised seven cancer-specific drugs and three for varied diseases and conditions. Therefore, the mounting demand for personalized medicine promotes the expansion of the RNA sequencing services market in the future.

What Segment Types Define the RNA Sequencing Services Market Structure?

The rna sequencing servicesmarket covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA); Transfer RNA (tRNA); Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods; Other Sequencing Methods

3) By Application Area: Research Purposes; Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing; RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling; TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling; lncRNA Sequencing

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the RNA Sequencing Services Market?

North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Emerging Trends that Are Influencing theRNA Sequencing Services Industry Evolution?

Key players in the RNA sequencing services market are shifting towards automation to minimize possible human mistakes, such as employing next-generation sequencing (NGS) assay. This technique is aimed at increasing efficiency and precision in the generation and assessment of data. RNA next-generation sequencing (RNA-seq) assay, a valuable mechanism in molecular biology and genomics, facilitates the examination of a biological sample’s transcriptome. Tempus, an American precision medicine technology firm, launched its standalone RNA next-generation sequencing assay known as Tempus xR in June 2023, as an example. This groundbreaking assay, created for solid tumors, carries out a thorough evaluation of the entire transcriptome. It pinpoints clinically important fusions in over 100 target genes, and detects altered splicing for MET Exon 14 and EGFRvIII. Tempus, understanding the importance of RNA sequencing data, has traditionally integrated both RNA and DNA sequencing in its universal xT broad-panel assay. Today, customers can choose to purchase each test individually or at the same time, and have the choice to complement xR with selected Tempus algorithmic tests. This service is suited for doctors who are particularly interested in RNA fusions or altered splicing, and for providers, researchers, and biopharma firms that require a comprehensive RNA sequencing analysis of their current samples.

View the full report here:

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

What Is the Definition of the RNA Sequencing Services Market?

RNA sequencing is a high-throughput technique used to analyze the presence and quantity of RNA molecules within a sample, providing insights into gene expression levels and transcriptomic dynamics. It is used to explore gene expression patterns and regulatory mechanisms in many biological processes, such as development, illness, and response to stimuli.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14991

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the RNA Sequencing Services Market Grown from 2024 to 2025?

There has been a swift expansion in the size of the RNA sequencing services market in the last few years. The market’s growth is projected to surge from $3.58 billion in 2024 to $4 billion in 2025, registering a compound annual growth rate (CAGR) of 11.6%. The substantial growth experienced in the past can be accredited to the escalating demand for personalized medicine, progress in bioinformatics tools, a growing emphasis on drug discovery and development, an increased tendency for RNA sequencing in agricultural research, and widening uses in clinical diagnostics.

What Growth Rate Is Anticipated for the RNA Sequencing Services Market in the Coming Years?

A significant expansion is expected in the RNA sequencing services market in the coming years, with predictions of it reaching $6.13 billion by 2029, displaying a compound annual growth rate (CAGR) of 11.3%. The expected growth within this forecast period is linked to the development of single-cell RNA sequencing technologies, the incorporation of artificial intelligence and machine learning into data examination, the growing research around non-coding RNA biomarkers, and an increased requirement for transcriptomic analysis in immunotherapy research. Moreover, growing partnership between academic institutions and industry players in genomic research is another driving factor. Prominent trends for this period include the adoption of long-read sequencing, the use of cloud-based analysis platforms, increased demand for RNA splicing analysis, and the integration of multi-omics data.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

Who Are the Leading Companies in the RNA Sequencing Services Market?

Major companies operating in the RNA sequencing services market are Thermo Fisher Scientific Inc., Feng Chi Biotech Corp., Illumina Inc., Qiagen NV, BGI Genomics Co. Ltd., Azenta Inc., Abcam Limited, Novogene Co. Ltd., Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, RayBiotech Inc., Genomax Technologies Pte. Ltd., Phalanx Biotech Group Inc., Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics

What Are the Key Drivers of the RNA Sequencing Services Market?

The surge in the need for customized medicinal treatment is playing a substantial role in propelling the RNA sequencing services industry’s growth. Customized medicine involves adapting healthcare treatments to suit individual traits such as genetics or lifestyle, to maximize efficiency and reduce negative effects. This spike in demand for personalized medical care is influenced by its capacity to provide more efficient treatments, advancements in genomics, evolving disease complexity, and legislative support. RNA sequencing services aid in determining disease variants, finding biomarkers, identifying therapeutic targets, forecasting therapy responses, and monitoring disease progression and treatment outcomes. Customized medical practices employ RNA sequencing technologies to provide personalized and effective drugs, catering to the unique molecular specifics of individual patients. For example, in February 2024, the Personalized Medicine Coalition, a not-for-profit organization based in the US, reported that the FDA (Food and Drug Administration) sanctioned 16 new personalized therapies for patients with uncommon diseases in 2023, a significant increase from six in 2022. The freshly approved personalized treatments in 2023 also comprised seven drugs for cancer and three for other disease types and conditions. Hence, the escalating demand for customized medicine is stimulating the growth of the RNA sequencing services market in the future.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp

What Are the Key Market Segments in the RNA Sequencing Services Industry?

The RNA sequencing services market covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods

3) By Application Area: Research Purposes, Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing

What Are the Latest Trends in the RNA Sequencing Services Market?

Major corporations in the RNA sequencing services sector are focusing on incorporating automation to minimise possible human errors like the next-generation sequencing (NGS) assay with the goal of increasing productivity and precision in data creation and interpretation. RNA next-generation sequencing (RNA-seq) assay, a crucial instrument used in genomics and molecular biology, provides an in-depth examination of the transcriptome of a biological sample. Taking a case in point, Tempus, a precision medicine technology entity based in the US, launched its distinct RNA-next generation sequencing assay known as Tempus xR in June 2023. Primarily designed for solid tumours, this novel assay provides an exhaustive analysis of the complete transcriptome and identifies clinically significant fusions in more than 100 targeted genes, including altered splicing for MET Exon 14 and EGFRvIII. Acknowledging the relevance of RNA sequencing data, Tempus has factored in both RNA and DNA sequencing into its standard xT broad-panel assay traditionally. At present, customers can opt to order each test separately or concurrently while availing the opportunity to supplement xR with particular Tempus algorithmic tests. This service is specifically tailored for physicians interested in RNA fusions or altered splicing, and for providers, researchers, and biopharma companies looking for an in-depth RNA sequencing analysis of their available samples.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

What Are the Key Regional Markets in the RNA Sequencing Services Industry?

North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14991

This Report Delivers Insight On:

1. How big is the rna sequencing services market, and how is it changing globally?

2. Who are the major companies in the rna sequencing services market, and how are they performing?

3. What are the key opportunities and risks in the rna sequencing services market right now?

4. Which products or customer segments are growing the most in the rna sequencing services market?

5. What factors are helping or slowing down the growth of the rna sequencing services market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the rna sequencing services industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

How Has The RNA Sequencing Services Market Size Shifted, And What Is the Outlook Through 2034?

In recent times, there’s been significant expansion in the market size of RNA sequencing services. The market, which stands at $3.58 billion in 2024, is predicted to rise to $4 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.6%. The acceleration observed during the historic period is likely due to factors such as the rising demand for individualized treatment, improvement in bioinformatics tools, an amplified focus on the discovery and development of drugs, increased use of RNA sequencing for agricultural research, and its growing applications in the domain of clinical diagnostics.

The market size for RNA sequencing services is anticipated to experience accelerated expansion in the forthcoming years. It is predicted to escalate to $6.13 billion in 2029, with a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this increase during the forecast period include the rise of single-cell RNA sequencing technologies, the incorporation of artificial intelligence and machine learning into data analysis, extension of research into non-coding RNA biomarkers, an escalating requirement for transcriptomic analysis in immunotherapy research, and burgeoning partnerships between academia and industry in genomic studies. Significant trends during the forecast period comprise the adoption of long-read sequencing, cloud-based analysis platforms, a surge in the need for RNA splicing analysis, and the integration of multi-omics data.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the RNA Sequencing Services Market?

The RNA sequencing services market is experiencing significant growth as a result of the increasing demand for personalized medicine. Personalized medicine aims to optimize treatment effectiveness and reduce adverse effects by customizing medical treatment based on individual characteristics like genetics or lifestyle. This increasing demand is driven by its promise of more effective treatments, advancements in genomics, growing complexity of diseases and regulatory support. RNA sequencing services play a crucial role in this scenario by identifying disease subtypes, discovering biomarkers, determining therapeutic targets, predicting responses to therapy, and tracking disease progression and treatment results. Personalized medicine leverages RNA sequencing technologies to develop customized medicines that cater to the particular molecular characteristics of each individual patient. For instance, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the US, stated that the FDA (Food and Drug Administration) had approved 16 new personalized therapies in 2023 for patients with rare diseases, compared to six in 2022. The newly approved 2023 personalized treatments included seven cancer drugs and three for other diseases and conditions. Therefore, the escalation in the demand for personalized medicine underpins the growth trajectory of the RNA sequencing services market.

Which Key Market Segments Comprise the RNA Sequencing Services Market and Drive Its Revenue Growth?

The RNA sequencing services market covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods

3) By Application Area: Research Purposes, Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp

Which Areas Are Leading Regions in the RNA Sequencing Services Market Expansion Across the Globe?

North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theRNA Sequencing Services Market Over the Coming Years?

Prominent entities in the RNA sequencing services market, such as next-generation sequencing (NGS) assays, are moving towards automation to curtail possible human errors while enhancing effectiveness and preciseness in data creation and examination. The RNA Next Generation Sequencing (RNA-seq) assay serves as an efficacious instrument in the realms of genomics and molecular biology for evaluating the transcriptome of a biological specimen. As an illustration, Tempus, a U.S.-based precision medicine technology enterprise, introduced its exclusive RNA next-gen sequencing assay, Tempus xR in June 2023. Crafted for solid tumors, this pioneering assay enables a complete study of the transcriptome, emphasizing clinically significant fusions across over 100 targeted genes and altered splicing for MET exon 14 and EGFRvIII. Realizing the importance of RNA sequencing data, Tempus has traditionally included both RNA and DNA sequencing in its conventional xT broad-panel assay. Presently, clients can opt to order each test individually or in unison and can choose to enhance xR with select Tempus algorithmic exams. This service adjustment caters to doctors with a particular inclination towards RNA fusions or altered splicing, in addition to providers, researchers, and biopharmaceutical corporations seeking an exhaustive RNA sequencing examination of their current samples.

View the full report here:

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

How Is the RNA Sequencing Services Market Conceptually Defined?

RNA sequencing is a high-throughput technique used to analyze the presence and quantity of RNA molecules within a sample, providing insights into gene expression levels and transcriptomic dynamics. It is used to explore gene expression patterns and regulatory mechanisms in many biological processes, such as development, illness, and response to stimuli.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14991

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the RNA Sequencing Services Market?

The rise in popularity of personalized medicine is playing a crucial role in the expansion of the RNA sequencing services market. Personalized medicine aims to customize medical treatments according to the unique characteristics of individuals, such as genetic background or lifestyle, to enhance effectiveness and reduce unwelcome effects. The accelerated demand for personalized medicine is fueled by its capability to offer more efficient treatments, developments in the field of genomics, escalating disease complexity, and supportive regulations. RNA sequencing services aid in distinguishing disease subtypes, uncovering biomarkers, pinpointing therapeutic targets, forecasting therapy responses, and monitoring disease progression and treatment outcomes. The techniques of personalized medicine utilize RNA sequencing technologies to develop individualized and potent medicines that address the specific molecular attributes of individual patients. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the U.S., reported that in 2023, the FDA (Food and Drug Administration) approved 16 new personalized therapies for patients with rare diseases, a significant increase from six in 2022. The approved personalized treatments in 2023 included seven cancer drugs and three for other diseases and conditions. Consequently, the mounting demand for personalized medicine propels the growth of the RNA sequencing services market in the future.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

#What is the Growth Potential of the RNA Sequencing Services Market, and How Will It Perform by 2034?

In recent years, the market size for RNA sequencing services has experienced swift growth. Projected to see an increase from $3.58 billion in 2024 to $4 billion in 2025, the market enjoys a compound annual growth rate (CAGR) of 11.6%. This growth during the historical period can be credited to the rising demand for personalized medicine, progress in bioinformatics tools, amplified focus on drug discovery and development, increased adoption of RNA sequencing in the field of agricultural research, and the broadening of its use in clinical diagnostics.

The market size of RNA sequencing services is projected to expand rapidly in the forthcoming years, and is expected to reach a value of $6.13 billion by 2029 with a compound annual growth rate (CAGR) of 11.3%. This prospective growth during the projection period can be traced back to the rise of single-cell RNA sequencing technologies, the incorporation of artificial intelligence and machine learning in data interpretation, increasing research into non-coding RNA biomarkers, a surge in the demand for transcriptomic analysis in immunotherapy research, and heightened collaboration levels between academic and industrial sectors in genomic studies. The forecast period is likely to see significant trends such as the adoption of long-read sequencing, the use of cloud-based analysis platforms, rising demand for RNA splicing analysis, and the integration of multi-omics data.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14991

What Are the Key Market Innovations in theRNA Sequencing Services Market Over the Coming Years?

Large firms active in the RNA sequencing services sector are emphasizing automation to mitigate potential mistakes that could be introduced by human involvement, with the focus on next-generation sequencing (NGS) assays, which aim to improve efficiency and reliability in the creation and examination of data. The RNA-seq assay, a high-efficiency tool used in molecular biology and genomics, serves as a means for in-depth analysis of a biological sample’s transcriptome. To illustrate, in June 2023, the US firm Tempus, which specializes in precision medicine technology, introduced its standalone RNA NGS assay, Tempus xR. This inventive assay, designed specifically for solid tumours, presents a thorough overview of the transcriptome, underlining significant fusions in over 100 genes specifically targeted, in addition to altered splicing for MET Exon 14 and EGFRvIII. Tempus, acknowledging the importance of RNA sequencing data, traditionally includes both RNA and DNA sequencing in its standard xT broad-panel assay. Currently, customers can choose to order each test individually or in combination, also with the possibility to expand xR with specific Tempus algorithmic tests. This service is aimed at healthcare professionals with interest in RNA fusions or altered splicing, and also at providers, researchers, and biopharma companies who want extensive RNA sequencing analysis of their existing samples.

Who Are the Top Companies Driving Innovation and Growth in theRNA Sequencing Services Market?

Major companies operating in the RNA sequencing services market are Thermo Fisher Scientific Inc., Feng Chi Biotech Corp., Illumina Inc., Qiagen NV, BGI Genomics Co. Ltd., Azenta Inc., Abcam Limited, Novogene Co. Ltd., Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, RayBiotech Inc., Genomax Technologies Pte. Ltd., Phalanx Biotech Group Inc., Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

Which Key Market Segments Comprise the RNA Sequencing Services Market and Drive Its Revenue Growth?

The RNA sequencing services market covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods

3) By Application Area: Research Purposes, Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=14991&type=smp

Which Regions Are Emerging as Leaders in the RNA Sequencing Services Market?

North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global RNA Sequencing Services Market 2025, By The Business Research Company:

Clinical Oncology Next Generation Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

RNA Targeting Small Molecule Drug Discovery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecule-drug-discovery-global-market-report

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the rna sequencing services market right now?

The RNA sequencing services market has grown significantly, set to increase from $3.58 billion in 2024 to $4 billion in 2025, at a CAGR of 11.6%. Historical growth factors include rising demand for personalized medicine, advancements in bioinformatics, emphasis on drug discovery, adoption in agricultural research, and expanded applications in clinical diagnostics.

How fast Is the rna sequencing services market expected to grow, and what’s its future value?

The RNA sequencing services market is expected to expand significantly, reaching $6.13 billion in 2029 at a CAGR of 11.3%. Growth is driven by single-cell RNA sequencing advancements, AI and ML-based data analysis, non-coding RNA biomarker research, demand for transcriptomic analysis in immunotherapy, and academia-industry collaborations. Key trends include long-read sequencing adoption, cloud-based analysis, RNA splicing analysis demand, and multi-omics data integration.

Get your rna sequencing services market report here!

https://www.thebusinessresearchcompany.com/report/rna-sequencing-services-global-market-report

What are the leading drivers of growth in the rna sequencing services market?

The surge in necessity for personalized medicine is playing a pivotal role in driving the expansion of the RNA sequencing services market. Personalized medicine implies the adaptation of healthcare treatment to unique individual traits like genetics or lifestyle, with a view to amplify effectiveness and minimize detrimental effects. The escalating need for personalized medicine is stimulated by its inherent capability to proffer more efficient treatments, advancements in the sector of genomics, heightened complexity of diseases, and regulatory backing. RNA sequencing services facilitate the classification of various disease subtypes, discovering biomarkers, the determination of therapeutic targets, predictions of treatment responses and the surveillance of disease progression and treatment outcomes. Personalized medicine methodologies utilize RNA sequencing technologies to deliver customized and efficient medications that target the distinctive molecular characteristics of individual patients. As an illustration, the Personalized Medicine Coalition, a non-profit organization based in the US, reported that in February 2024, the FDA (Food and Drug Administration) sanctioned 16 unique personalized therapies for patients diagnosed with rare diseases in 2023, a significant increase compared to six in 2022. The approved personalized therapies in 2023 also included seven drugs for cancer and three for other diseases and conditions. Consequently, the intensifying demand for personalized medicine is catalyzing the expansion of the RNA sequencing services market in the forthcoming period.

What are the key segments defining the rna sequencing services market?

The RNA sequencing services market covered in this report is segmented –

1) By Type: Ribosomal RNA (rRNA), Transfer RNA (tRNA), Long non-coding RNA (lncRNA)

2) By Sequencing Method: Next Generation Sequencing Methods, Other Sequencing Methods

3) By Application Area: Research Purposes, Diagnostic Purposes

4) By End Users: Academic And Government Institutes And Research Centers, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End Users

Subsegments:

1) By Ribosomal RNA (rRNA): Total RRNA Sequencing, RRNA Depletion

2) By Transfer RNA (tRNA): TRNA Profiling, TRNA Sequencing

3) By Long Non-Coding RNA (lncRNA): lncRNA Profiling, lncRNA Sequencing

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=14991&type=smp

Who are the key players steering the development of the rna sequencing services market?

Major companies operating in the RNA sequencing services market are Thermo Fisher Scientific Inc., Feng Chi Biotech Corp., Illumina Inc., Qiagen NV, BGI Genomics Co. Ltd., Azenta Inc., Abcam Limited, Novogene Co. Ltd., Genewiz Inc., Diagenode LLC, CD Genomics, CeGaT GmbH, Lexogen GmbH, BaseClear BV, Active Motif Inc., Microsynth AG, RayBiotech Inc., Genomax Technologies Pte. Ltd., Phalanx Biotech Group Inc., Creative Biogene, SeqMatic LLC, Genohub Inc., Otogenetics, LC Sciences, Admera Health, Arraystar Inc., IGA Technology, Yaazh Xenomics

What emerging trends are influencing the growth of the rna sequencing services market?

Key players in the RNA sequencing services market are prioritizing automation to minimize the risk of human error, exemplified through next-generation sequencing (NGS) assay, with the goal of improving both efficiency and precision in generating and analyzing data. RNA next-generation sequencing (RNA-seq) assays are valuable tools in the domains of molecular biology and genomics, enabling the exploring of a biological sample’s transcriptome. For instance, in June 2023, the U.S-based precision medicine technology firm, Tempus, introduced its independent RNA next-generation sequencing assay, Tempus xR. This trailblazing assay, developed for solid tumors, provides an in-depth analysis of the entire transcriptome and draws attention to clinically relevant fusions in over 100 targeted genes, along with altered splicing for MET Exon 14 and EGFRvIII. Understanding the importance of RNA sequencing data, Tempus has historically merged both RNA and DNA sequencing in its standard xT broad-panel assay. Presently, clients can choose to order each test independently or together, and have the option to enhance xR with certain Tempus algorithmic tests. This service accommodates physicians interested in RNA fusions or altered splicing, as well as service providers, investigators, and biopharmaceutical firms aiming for comprehensive RNA sequencing analysis of their existing samples.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14991

Which regions are most influential in expanding the rna sequencing services market?

North America was the largest region in the RNA sequencing services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the RNA sequencing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Clinical Oncology Next Generation Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

RNA Targeting Small Molecule Drug Discovery Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecule-drug-discovery-global-market-report

Messenger ribonucleic acid (mRNA) Synthesis Raw Materials Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/messenger-ribonucleic-acid-mrna-synthesis-raw-materials-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: